Becton Dickinson And 

CHF245.48
728
+CHF0+0% Tuesday 14:30

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
45.7
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Mar 25
CHF0.85
Dec 24
CHF0.85
Sep 24
CHF0.85
Jun 24
CHF0.85
Mar 24
CHF0.85
10Y Growth
6.08%
5Y Growth
3.02%
3Y Growth
4.85%
1Y Growth
1.64%

Earnings

30AprExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
2.21
2.79
3.38
3.96
Expected EPS
2.775
Actual EPS
N/A

Financials

9.08%Profit Margin
Profitable
2017
2018
2019
2020
2021
2022
18.32BRevenue
1.66BNet Income

Analyst Ratings

$194.25Average Price Target
The highest estimate is 221.29.
From 11 ratings within the last 6 months. This is not an investment recommendation.
Buy
55%
Hold
45%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BDX.SW. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap116.33B
Medtronic competes directly with Becton Dickinson in the medical devices sector, particularly in areas like surgical instruments and diabetes care products.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories offers a wide range of medical devices, diagnostics, and nutritional products that compete with Becton Dickinson's offerings.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific competes in the supply of laboratory equipment and consumables, directly challenging Becton Dickinson's life sciences segment.
Danaher
DHR
Mkt Cap152.13B
Danaher Corporation's life sciences and diagnostics divisions offer products that compete with Becton Dickinson's portfolio, especially in diagnostics and research.
Stryker
SYK
Mkt Cap136.19B
Stryker Corporation is a competitor in the medical technology field, particularly in surgical equipment and hospital beds, areas where Becton Dickinson also operates.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific Corporation competes with Becton Dickinson in the medical devices market, especially in areas like cardiovascular and endoscopy products.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson's medical devices division offers products that compete across several of Becton Dickinson's key areas, including surgical instruments and infection prevention.
Hologic
HOLX
Mkt Cap16.45B
Hologic, Inc. competes with Becton Dickinson in the diagnostics and women's health sectors, offering similar products for cancer detection and surgical procedures.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet Holdings, Inc. competes in the musculoskeletal healthcare sector, which overlaps with Becton Dickinson's solutions for surgical and rehabilitation products.
Intuitive Surgical
ISRG
Mkt Cap189.4B
Intuitive Surgical, Inc. competes with Becton Dickinson in the surgical instruments market, particularly with its robotic-assisted surgical systems.

About

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Show more...
CEO
ISIN
US0758871091
WKN
000857675

Listings

0 Comments

Share your thoughts

FAQ

What is Becton Dickinson And stock price today?
The current price of BDX.SW is CHF245.48 CHF — it has increased by +0% in the past 24 hours. Watch Becton Dickinson And stock price performance more closely on the chart.
What is Becton Dickinson And stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Becton Dickinson And stocks are traded under the ticker BDX.SW.
What is Becton Dickinson And revenue for the last year?
Becton Dickinson And revenue for the last year amounts to 18.32B CHF.
What is Becton Dickinson And net income for the last year?
BDX.SW net income for the last year is 1.66B CHF.
Does Becton Dickinson And pay dividends?
Yes, BDX.SW dividends are paid quarterly. The last dividend per share was 0.85 CHF. As of today, Dividend Yield (FWD)% is 0%.
When did Becton Dickinson And complete a stock split?
Becton Dickinson And has not had any recent stock splits.